Opinion|Videos|June 1, 2024

The Evolving Treatment Landscape in BCG-Unresponsive NMIBC

Bladder cancer experts discuss the evolving treatment landscape in BCG-unresponsive NMIBC and give an overview of TAR-200, an emerging therapy.